Screener
Ligand Pharmaceuticals LGND Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's operating margin?
- Ligand Pharmaceuticals (LGND) reported operating margin of 32.6% in Q2 2026.
- How has Ligand Pharmaceuticals's operating margin changed year-over-year?
- Ligand Pharmaceuticals's operating margin increased by 278.5% year-over-year, from -18.3% to 32.6%.
- What is the long-term trend for Ligand Pharmaceuticals's operating margin?
- Over 3 years (2020 to 2025), Ligand Pharmaceuticals's operating margin has grown at a -8.7% compound annual growth rate (CAGR), from 20.1% to 15.3%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Ligand Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude